about
Epigenetic modifications in cancerICBP90, a novel methyl K9 H3 binding protein linking protein ubiquitination with heterochromatin formationPhytochemicals modulate carcinogenic signaling pathways in breast and hormone-related cancersEpigenetic alterations in the suprachiasmatic nucleus and hippocampus contribute to age-related cognitive declineEpigenetic diet: impact on the epigenome and cancerStructural and Functional Profiling of the Human Histone Methyltransferase SMYD3Identification of candidate methylation-responsive genes in ovarian cancerInhibitory effect of HGF on invasiveness of aggressive MDA-MB231 breast carcinoma cells, and role of HDACs.Application of histone modification in the risk prediction of the biochemical recurrence after radical prostatectomy.Histone H1x is highly expressed in human neuroendocrine cells and tumours.Identification of genes in HepG2 cells that respond to DNA methylation and histone deacetylation inhibitor treatmentPromoter Methylation in Prostate Cancer and its Application for the Early Detection of Prostate Cancer Using Serum and Urine Samples.Epigenetics and cancer.Cancer chemoprevention by dietary polyphenols: promising role for epigenetics.Butyrate, an HDAC inhibitor, stimulates interplay between different posttranslational modifications of histone H3 and differently alters G1-specific cell cycle proteins in vascular smooth muscle cells.Transmembrane potential of GlyCl-expressing instructor cells induces a neoplastic-like conversion of melanocytes via a serotonergic pathway.Epigenetic targets of bioactive dietary components for cancer prevention and therapy.DNA methylation and microRNA biomarkers for noninvasive detection of gastric and colorectal cancer.Histone deacetylase regulation of immune gene expression in tumor cells.Histone deacetylase inhibitors induce TAP, LMP, Tapasin genes and MHC class I antigen presentation by melanoma cellsThe crossroads between cancer stem cells and aging.Epigenomics of ovarian cancer and its chemoprevention.Glioma revisited: from neurogenesis and cancer stem cells to the epigenetic regulation of the nicheMassively parallel bisulphite pyrosequencing reveals the molecular complexity of breast cancer-associated cytosine-methylation patterns obtained from tissue and serum DNA.Methylation of tumor suppressor genes in ovarian cancer.Epigenetic hereditary transcription profiles II, aging revisited.Single-Cell Quantification of Cytosine Modifications by Hyperspectral Dark-Field Imaging.Identification of metabolites with anticancer properties by computational metabolomicsThe histone deacetylase inhibitor PCI-24781 as a putative radiosensitizer in pediatric glioblastoma cell lines.Hsp90--from signal transduction to cell transformation.Modulation of potassium channel function confers a hyperproliferative invasive phenotype on embryonic stem cells.Regulation of demethylation and re-expression of RASSF1A gene in gastric cancer cell lines by combined treatment of 5-Aza-CdR and NaBDifferential cellular and molecular effects of butyrate and trichostatin a on vascular smooth muscle cells.Epigenetic changes in carcinogenesis of gallbladderEpigenetics in human melanoma.Epigenetics of oropharyngeal squamous cell carcinoma: opportunities for novel chemotherapeutic targets.Elevated expression of RNA methyltransferase BCDIN3D predicts poor prognosis in breast cancer.Novel treatment regimens for Waldenström's macroglobulinemia.An overview of cancer chemopreventive potential and safety of proanthocyanidins.DNA methylation and cancer development: molecular mechanism.
P2860
Q22242610-22808707-054D-4792-AB17-4BB3612960E8Q24298944-8775860D-50A2-4D80-B633-1AA7580A8E94Q26798324-3267BA5E-C566-43DE-B15A-0D4BC0A29A89Q26801158-7CB2C0F7-76B0-448F-891B-8CDD19716722Q27022002-4444AD46-6166-4429-8940-9C57FA59F281Q27670941-1626DC56-8965-46D7-A832-8F9B3E2239FBQ28395229-8556E0BB-9CAE-4BDF-84EE-F53BBFF63F9DQ30437958-6EE30765-0ABC-44AF-A4A3-69AB7BB621F4Q30911744-B0B51E54-5542-41C1-A892-EB7B5A16B25EQ33395865-59DF0A31-24D1-40AA-824E-C4FFAF289EA6Q33962216-8C976493-0DC2-40BF-A495-DCE8250A0DC1Q34014559-9F68408D-1296-4850-94B8-F553087CA557Q34085532-A385045E-3A02-4D95-8473-F68428714C77Q34279875-C73AE825-4742-4232-B751-86892E8925F9Q34384713-E5442A03-D849-4177-A943-35535C340197Q34435259-3302134A-8FDF-4382-9A76-81B8FE521064Q34508252-F7FFB2BF-A46E-4B5E-BA53-3298AD364902Q34603514-EB30D451-58A7-4053-9127-CF344DCE2B64Q35092304-11F633C3-5FA5-436E-84F0-63F5FA79BAABQ35136002-6D1BEBAB-72E7-4437-A963-E21708843E1AQ35566484-66B944AB-CD03-4A32-9F21-F0442E5C173FQ35711392-50403A45-FC1F-4BC2-9134-16B4E7F08FEEQ36225175-D320B3F0-101D-48E9-B506-2279C7074E25Q36259313-182A11A4-F9B1-4EC5-99B4-4A85F24DA931Q36386613-63F460D5-C1D2-4BB7-AB00-E774E8DBF07DQ36492250-5974134C-BBF6-4E6F-996F-3C86AAE11EFFQ36614718-83AD4569-6796-488E-BB88-60473D7E10A4Q36755528-68318BB2-C6DE-4063-A09B-E9DF6247AF3EQ36810416-E43D41EC-5404-4DDB-92E9-733C8B8ABD37Q36934856-232923E7-A7FF-4EAF-98F7-E6F9C6C4C2A5Q36954915-5C602ECF-B0FC-4F7C-A006-5D15AF99AA93Q37189609-AD4414AD-8934-4149-906A-5076EFABDD7CQ37277291-BF177EFA-7CE3-4255-94AF-C92813EB10F0Q37471592-93BFAD3D-5F2D-441C-9070-87DA730E4862Q37531849-0A56FDF0-5C97-4A92-9131-3397229408B4Q37615798-A0B603AF-481C-4AA4-91B4-A73D3D68D403Q37619842-4939F0BB-A523-4AE8-AD69-E7E2EDE11759Q37810101-9ADAAD29-2E61-458D-B67F-4D61C6BEF3EFQ37949394-99275BCE-5C77-4B17-8C64-CD4CE1FB6D31Q38091024-0FE817FE-A6C5-4521-99A7-16B55E70A087
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Epigenetic aberrations and cancer.
@ast
Epigenetic aberrations and cancer.
@en
type
label
Epigenetic aberrations and cancer.
@ast
Epigenetic aberrations and cancer.
@en
prefLabel
Epigenetic aberrations and cancer.
@ast
Epigenetic aberrations and cancer.
@en
P2860
P921
P356
P1433
P1476
Epigenetic aberrations and cancer.
@en
P2093
Mark A Brown
Miryam Ducasse
P2860
P2888
P356
10.1186/1476-4598-5-60
P5008
P577
2006-11-08T00:00:00Z
P5875
P6179
1013875184